Gentherm (THRM) Q1 2026 earnings review
Record Q1 Revenue and Transformational M&A Mask Underlying Macro Weakness
Gentherm delivered an Accelerating Q1, with revenue climbing 11.3% YoY to a record $394 million, decisively snapping the flat growth trend of early 2025. Adjusted EPS surged to $0.84 (up from $0.51). The biggest news, however, was strategic: Gentherm is acquiring Modine Performance Technologies to diversify away from light vehicle dependency. Despite the Q1 beat, full-year guidance was maintained rather than raised, reflecting a Decelerating macro environment where global light vehicle production is expected to shrink. While operational leverage drove gross margin expansion, negative operating cash flow highlights persistent working capital drags.
🐂 Bull Case
Automotive Climate and Comfort Solutions revenue grew 13.6% (9.8% ex-FX), outperforming global light vehicle production by a massive 14 percentage points. The company is successfully increasing content per vehicle.
Gross margin expanded to 24.7% from 24.4%, driven by operational initiatives and net material performance, proving management's footprint realignment is beginning to yield bottom-line results.
🐻 Bear Case
Despite Q1's double-digit revenue jump, FY26 guidance remains anchored at $1.5B–$1.6B. Management anticipates light vehicle production in relevant markets will decline at a low single-digit rate for the remainder of the year.
Operating cash flow was negative $5.0 million. Rising accounts receivable ($26.3 million drag) are consuming cash, raising questions about collection timing and working capital efficiency amid top-line growth.
⚖️ Verdict: ⚪
Neutral. The core automotive business is heavily outperforming underlying production, and the Modine acquisition is a smart diversification play. However, stagnant FY26 guidance, negative cash flow, and a shrinking Medical segment cap near-term upside.
Key Themes
Lumbar and Massage Segment is the Primary Growth Engine
Accelerating. Lumbar and Massage Comfort Solutions surged 37.4% YoY to $62.3 million. This segment has consistently been Gentherm's strongest performer, proving that automakers are increasingly adopting pneumatic comfort technologies beyond ultra-luxury platforms.
Transformational Pivot: Modine Performance Technologies
Gentherm announced a combination with Modine Performance Technologies, expected to close in late 2026. This is a critical driver for future growth, establishing the company as a leader in precision flow management across heavier equipment and non-automotive end markets, actively reducing its exposure to volatile consumer auto cycles.
Adjacent Markets Yielding Tangible Deliveries
Management's strategy to repurpose automotive technology for adjacent markets is moving from concept to revenue. Gentherm delivered its first home and office solutions to KUKA Home in Asia this quarter, providing a capital-light avenue for incremental revenue.
Contradiction: Medical Segment Shrinking Despite Innovation Hype
Reversing. In previous quarters, management touted Medical as a high-growth adjacent market. Furthermore, they just submitted the ThermAffyx Patient Safety System for FDA approval. Yet, actual Q1 Medical revenue fell 3.7% YoY (and 6.3% ex-FX) to $11.5 million. The positive product narrative is currently directly contradicted by shrinking sales data.
Macro Deceleration: Light Vehicle Production
Decelerating. The company noted that S&P Global’s mid-April report forecasts a low-single-digit decline in light vehicle production in Gentherm's relevant markets for 2026. This macro drag is the explicit reason FY26 guidance implies a significant slowdown in growth for the remaining three quarters.
Tariff Policy Risk Remains Baked In
Guidance explicitly assumes 'tariffs currently in effect as of today.' With highly integrated cross-border supply chains (particularly in Mexico), any sudden shifts in US trade policy could rapidly compress margins or force price hikes that damage OEM relationships.
Other KPIs
Reversing. OCF remains negative, though improved from $(13.3) million a year ago. The primary culprit is a $26.3 million increase in Accounts Receivable. While AR growth is natural during a quarter with 11% revenue growth, sustained negative cash flow limits the company's internal funding capacity ahead of the Modine integration.
Stable. Gentherm enters the Modine transaction with an exceptionally clean balance sheet. Cash and equivalents sit at $177.4 million. This low leverage profile (down from 0.6x a year ago) provides ample capacity to finance the upcoming acquisition without stressing the business.
Accelerating. Restructuring expenses rose from $4.5 million in the prior year. This reflects the ongoing, aggressive global manufacturing footprint realignment (shifting production out of higher-cost areas). While an immediate drag on GAAP earnings, it is the primary reason gross margins expanded this quarter.
Guidance
Decelerating. At the midpoint ($1.55B), this implies roughly 3.4% YoY growth compared to FY25's $1.498B. Given that Q1 just delivered 11.3% growth, this guidance implies a sharp deceleration in Q2-Q4, driven by the anticipated decline in global light vehicle production.
Stable. The $185M midpoint represents a 12.0% margin, which is a modest improvement over FY25's 11.7%. Management expects pricing concessions and higher labor costs to be offset by factory footprint optimization and volume leverage.
Accelerating. Compares to $61.1M delivered in FY25. Achieving this will require a drastic turnaround in working capital management in the back half of the year, as Q1 began in a $5 million operational deficit.
Key Questions
Modine Integration Pathway
With the Modine Performance Technologies combination set to close by the end of 2026, what are the immediate transition costs expected this year, and how will it impact the current $80M-$100M free cash flow guidance?
Medical Segment Disconnect
Medical segment revenues declined 6.3% ex-FX this quarter. Can management bridge the gap between the optimism surrounding the ThermAffyx FDA submission and the current deterioration in baseline segment sales?
Working Capital Dynamics
Accounts Receivable consumed $26.3 million in cash this quarter. Are OEMs pushing out payment terms, or is this strictly a function of back-end loaded intra-quarter shipping volumes?
Pricing vs Tariffs
Guidance relies on current tariffs. If trade policies shift unfavorably in the second half of 2026, how quickly can Gentherm pass those costs through to customers, and what is the expected margin dilution during the lag period?